Haselmeier has announced Paul Jansen has been appointed as its senior advisor and member of the board of directors.
This appointment helps serve objectives of Haselmeier as the innovation organisation within the Haselmeier Group.
Chief executive officer (CEO) at Haselmeier Gert Weber said: "Paul’s deep market insight and leadership experience in medical device development will be of great help to position Haselmeier as an innovative developer and manufacturer of drug delivery systems servicing Pharma and Biotech".
Paul Jansen brings nearly 30 years of experience in the medical device industry and is a well-respected member of the medical device community. Paul has managed several drug delivery systems development programmes, and groups, in particular at Eli Lilly in the early 2000s and in the Leadership of Global Medical Device Development at Sanofi since 2006. He is also part of several influential global advisory boards and committees in the MedTech industry, including his role as vice-chair of the ISO TC84 Committee.
Paul Jansen said: "I am excited to be able to work with the talented Haselmeier Team to strengthen the company’s reputation as a global provider of self-injection devices. I am anxious to start and work to accelerate innovation and development for patients."
As Member of the board of directors, Paul will be responsible to optimise the product portfolio strategy and its related intellectual property, as well as provide more access to innovative technology solutions and partners.